Net profit of Epigral rose 111.15% to Rs 103.63 crore in the quarter ended December 2024 as against Rs 49.08 crore during the previous quarter ended December 2023. Sales rose 36.84% to Rs 645.24 crore in the quarter ended December 2024 as against Rs 471.52 crore during the previous quarter ended December 2023.
Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
Sales | 645.24 | 471.52 | 37 |
OPM % | 28.29 | 25.99 | - |
PBDT | 186.53 | 104.81 | 78 |
PBT | 153.62 | 73.93 | 108 |
NP | 103.63 | 49.08 | 111 |